PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50325F80014Oseltamivir phosphate 75mg capsules (ndc — Exelan Pharmaceuticals Inc

Exelan Pharmaceuticals Inc holds $184.3M across 125 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79720D0227. Competition previously drew 3 offers. Recompete timing centers on the Jun 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Orm-Sns
Awarding office
Exelan Pharmaceuticals Inc
Recipient
Jun 29, 2027
PoP end
$74.1M
Obligated
325412
NAICS
6505
PSC
3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Exelan Pharmaceuticals Inc — $90

Contract facts

Federal
Contract number75A50325F80014
Also listed as36F79720D0227-75A50325F80014
AgencyAspr/Orm-Sns
Awarding officeAspr/Orm-Sns
IncumbentExelan Pharmaceuticals Inc
UEIFYZXNHSQTMG8
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0227
Place of performanceBOCA RATON, FL
Related solicitation75A50325Q00001
PoP end (current)Jun 29, 2027
Obligated$74.1M

OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 76282-0704-45); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES… is a federal award for Aspr/Orm-Sns held by Exelan Pharmaceuticals Inc. Estimated value $74.1M ($74.1M obligated). Current period of performance ends Jun 29, 2027. Last award drew 3 bidders. Place of performance: BOCA RATON, FL. Related solicitation 75A50325Q00001.

OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 76282-0704-45); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 76282-0702-45); 10 CT. BLISTERS PACKS.

Recompete timing

Public
Expiring in 313 days

Current PoP ends Jun 29, 2027 (313 days remaining). Agencies typically plan 12–18 months ahead — at 10.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Exelan Pharmaceuticals Inc$184.3M obligated across 125 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($184.3M) · all agencies
Department of Veterans Affairs (VA)$110.2M · 60%Department of Health and Human Services (HHS)$74.1M · 40%Department of Justice (DOJ)$39K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C24826N0088
LENALIDOMIDE
Department of Veterans Affairs (VA) · EXELAN PHARMACEUTICALS INC.
$3.8M
Sep 30, 2026
36C26326F0016
LENOLIDOMIDE CAPSULES
Department of Veterans Affairs (VA) · EXELAN PHARMACEUTICALS INC.
$3.6M
Sep 30, 2026
36C24726F0053
LENALIDOMIDE CAPSULES
Department of Veterans Affairs (VA) · EXELAN PHARMACEUTICALS INC.
$4.8M
Dec 7, 2026
36C24626N0410
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
Department of Veterans Affairs (VA) · EXELAN PHARMACEUTICALS INC.
$5.1M
Jan 14, 2027
36C24626N0416
LENALIDOMIDE FOR THE DURHAM VAMC FOR PATIENT CARE
Department of Veterans Affairs (VA) · EXELAN PHARMACEUTICALS INC.
$4.5M
Jan 14, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50325F80014?

75A50325F80014 (Oseltamivir phosphate 75mg capsules (ndc) is a Aspr/Orm-Sns award with an estimated value of $74.1M, currently held by Exelan Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50325F80014?

Aspr/Orm-Sns awarded 75A50325F80014 to Exelan Pharmaceuticals Inc.

Who is the incumbent on 75A50325F80014?

Exelan Pharmaceuticals Inc is the incumbent with $184.3M across 125 related awards in SCOUT’s public footprint. The current period of performance ends Jun 29, 2027.

When does Exelan Pharmaceuticals Inc’s 75A50325F80014 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50325F80014